Download Short Form

Information for Vermont Prescribers of Prescription Drugs (Short Form)
Information for Vermont Prescribers of Prescription Drugs (Short Form):
Pomalyst® (pomalidomide) capsules
*
This list provides pricing information for oral products listed in the antineoplastic drug
classification.
*
This list does not imply that the products on this chart are interchangeable or have the same
efficacy or safety. Please refer to each product's FDA-approved label and indication for further
information.
*
The prices listed below are Average Wholesale Prices (AWP) as established and made available
to the public by a third party publisher, or as calculated from data made available to the public
by a third party publisher. The price paid by consumers may be higher or lower than the prices
listed below. Information about AWP of these drugs is being provided to Vermont prescribers
pursuant to Vermont law, to give you information about the relative prices of marketed drugs and
other drugs in the same therapeutic class.
*
The prices listed here do not necessarily reflect price per dosage, price per course of
treatment, or the cost effectiveness of all the products listed. For simplicity, only the smallest
package sizes available for each product are included.
Price Comparison: Marketed product and lowest dosage of other products in same therapeutic class.*
Marketed Product
POMALYST CAP 1MG
Per Unit
$830.04
Other Products
MEGESTROL AC TAB 20MG
DROXIA CAP 200MG
HYDROXYUREA CAP 500MG
HYDREA CAP 500MG
TAMOXIFEN TAB 10MG
FLUTAMIDE CAP 125MG
METHOTREXATE TAB 2.5MG
MERCAPTOPUR TAB 50MG
LYSODREN TAB 500MG
CYCLOPHOSPH CAP 25MG
VENCLEXTA TAB 10MG
ANASTROZOLE TAB 1MG
CAPECITABINE TAB 150MG
MELPHALAN TAB 2MG
ALKERAN TAB 2MG
TEMOZOLOMIDE CAP 5MG
TREXALL TAB 5MG
LETROZOLE TAB 2.5MG
XELODA TAB 150MG
EMCYT CAP 140MG
BICALUTAMIDE TAB 50MG
HEXALEN CAP 50MG
ARIMIDEX TAB 1MG
EXEMESTANE TAB 25MG
CASODEX TAB 50MG
TEMODAR CAP 5MG
FEMARA TAB 2.5MG
MYLERAN TAB 2MG
LEUKERAN TAB 2MG
TABLOID TAB 40MG
TRETINOIN CAP 10MG
LYNPARZA CAP 50MG
GLEOSTINE CAP 5MG
AROMASIN TAB 25MG
FARESTON TAB 60MG
ZELBORAF TAB 240MG
TYKERB TAB 250MG
$0.87
$0.91
$1.26
$1.64
$1.89
$3.06
$4.25
$5.36
$5.76
$9.36
$10.32
$11.60
$12.10
$12.21
$13.58
$13.65
$15.96
$16.10
$16.27
$17.58
$18.27
$19.08
$19.09
$20.23
$21.00
$24.86
$28.08
$28.11
$29.19
$30.33
$33.62
$33.71
$37.56
$40.26
$49.98
$54.25
$54.37
Page 1 of 2
Information for Vermont Prescribers of Prescription Drugs (Short Form)
Marketed Product
ALECENSA CAP 150MG
TAFINLAR CAP 50MG
MATULANE CAP 50MG
INLYTA TAB 1MG
ZYTIGA TAB 250MG
ALUNBRIG TAB 30MG
ETOPOSIDE CAP 50MG
TARCEVA TAB 25MG
IMATINIB MES TAB 100MG
XTANDI CAP 40MG
KISQALI 200 PAK FEMARA
VOTRIENT TAB 200MG
GLEEVEC TAB 100MG
MEKINIST TAB 0.5MG
HYCAMTIN CAP 0.25MG
TASIGNA CAP 150MG
COTELLIC TAB 20MG
ZYKADIA CAP 150MG
SPRYCEL TAB 20MG
BOSULIF TAB 100MG
ZOLINZA CAP 100MG
RUBRACA TAB 200MG
IMBRUVICA CAP 140MG
RYDAPT CAP 25MG
NEXAVAR TAB 200MG
LONSURF TAB 15-6.14
ZEJULA CAP 100MG
SUTENT CAP 12.5MG
ZYDELIG TAB 100MG
COMETRIQ KIT 60MG
STIVARGA TAB 40MG
NILUTAMIDE TAB 150MG
JAKAFI TAB 5MG
KISQALI TAB 200DOSE
CAPRELSA TAB 100MG
NILANDRON TAB 150MG
BEXAROTENE CAP 75MG
LENVIMA CAP 8 MG
TARGRETIN CAP 75MG
GILOTRIF TAB 20MG
IRESSA TAB 250MG
XALKORI CAP 200MG
ODOMZO CAP 200MG
ERIVEDGE CAP 150MG
AFINITOR DIS TAB 2MG
AFINITOR TAB 2.5MG
TAGRISSO TAB 40MG
CABOMETYX TAB 20MG
IBRANCE CAP 75MG
ICLUSIG TAB 15MG
REVLIMID CAP 2.5MG
FARYDAK CAP 10MG
NINLARO CAP 2.3MG
Per Unit
$66.57
$71.39
$81.61
$91.20
$93.96
$95.00
$100.44
$100.76
$102.54
$102.98
$107.27
$110.19
$112.37
$117.39
$120.59
$124.15
$124.70
$126.43
$134.03
$135.39
$136.57
$137.40
$148.04
$160.61
$164.79
$178.47
$196.67
$199.52
$204.33
$211.27
$212.59
$225.24
$230.94
$250.29
$257.42
$259.05
$268.35
$290.50
$298.50
$302.03
$303.91
$305.83
$402.40
$461.46
$539.50
$542.20
$567.63
$606.38
$626.46
$662.44
$716.66
$1,466.67
$3,787.20
Medi-Span is the source of this information: July 11, 2017
*Prices shown are for the lowest dosage of each product. Prices for
multi-source products have been averaged. Multiple forms of the same
product (e.g. tabs and caps) have been considered one product, and the
prices have been averaged. Chewable forms of the product are not included.
For additional price comparison information see:
http://www.celgene.com/about/compliance/vermont-prescriber-information/
(c) 2014 Celgene Corporation 01/14 Us-CELG140004
Page 2 of 2